Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 297 entries
Sorted by: Best Match Show Resources per page
Post–acute care use and hospital readmission after sepsis

community settings

Small DS.
GSID: 2mcuQUulDysJ
TK Jones, BD Fuchs, DS Small, SD Halpern… - Annals of the …, 2015 - atsjournals.org

Rationale: The epidemiology of post–acute care use and hospital readmission after sepsis remains largely unknown. Objectives: To examine the rate of post–acute care use and …

Cite
Jones, T. K., Fuchs, B. D., Small, D. S., Halpern, S. D., Hanish, A., Umscheid, C. A., ... & Mikkelsen, M. E. (2015). Post–acute care use and hospital readmission after sepsis. Annals of the American Thoracic Society, 12(6), 904-913.
Jones, Tiffanie K., et al. "Post–acute care use and hospital readmission after sepsis." Annals of the American Thoracic Society 12.6 (2015): 904-913.
Copy Download .nbib Format: MLA
Iatrogenic exacerbation of pulmonary arteriovenous malformation in a patient with benign metastasizing leiomyoma.

Respirology case reports

Cadieux-Simard ML, Hennessey H, Small D, Daskalopoulou SS, Camlioglu E.
PMID: 25473552
Respirol Case Rep. 2014 Mar;2(1):15-7. doi: 10.1002/rcr2.34. Epub 2013 Dec 11.

We present a case of a middle-aged woman with known benign metastasizing leiomyoma presenting with pleural effusion. After ultrasound-guided drainage of the largest cyst was performed, the patient became hypoxemic. Chest computerized tomography (CT) showed a large tortuous vessel...

Cite
Cadieux-Simard ML, Hennessey H, Small D, et al. Iatrogenic exacerbation of pulmonary arteriovenous malformation in a patient with benign metastasizing leiomyoma. Respirol Case Rep. 2013;2(1):15-7doi: 10.1002/rcr2.34.
Cadieux-Simard, M. L., Hennessey, H., Small, D., Daskalopoulou, S. S., & Camlioglu, E. (2014). Iatrogenic exacerbation of pulmonary arteriovenous malformation in a patient with benign metastasizing leiomyoma. Respirology case reports, 2(1), 15-7. https://doi.org/10.1002/rcr2.34
Cadieux-Simard, Marie-Lie, et al. "Iatrogenic exacerbation of pulmonary arteriovenous malformation in a patient with benign metastasizing leiomyoma." Respirology case reports vol. 2,1 (2014): 15-7. doi: https://doi.org/10.1002/rcr2.34
Cadieux-Simard ML, Hennessey H, Small D, Daskalopoulou SS, Camlioglu E. Iatrogenic exacerbation of pulmonary arteriovenous malformation in a patient with benign metastasizing leiomyoma. Respirol Case Rep. 2014 Mar;2(1):15-7. doi: 10.1002/rcr2.34. Epub 2013 Dec 11. PMID: 25473552; PMCID: PMC4184722.
Copy Download .nbib Format: NLM
The COPE Intervention for Caregivers of Patients with Heart Failure: An Adapted Intervention.

Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association

McMillan SC, Small BJ, Haley WE, Zambroski C, Buck HG.
PMID: 24288455
J Hosp Palliat Nurs. 2013 Jun 01;15(4). doi: 10.1097/NJH.0b013e31827777fb.

No abstract available.

Cite
McMillan SC, Small BJ, Haley WE, et al. The COPE Intervention for Caregivers of Patients with Heart Failure: An Adapted Intervention. J Hosp Palliat Nurs. 2013;15(4)doi: 10.1097/NJH.0b013e31827777fb.
McMillan, S. C., Small, B. J., Haley, W. E., Zambroski, C., & Buck, H. G. (2013). The COPE Intervention for Caregivers of Patients with Heart Failure: An Adapted Intervention. Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association, 15(4), . https://doi.org/10.1097/NJH.0b013e31827777fb
McMillan, Susan C, et al. "The COPE Intervention for Caregivers of Patients with Heart Failure: An Adapted Intervention." Journal of hospice and palliative nursing : JHPN : the official journal of the Hospice and Palliative Nurses Association vol. 15,4 (2013). doi: https://doi.org/10.1097/NJH.0b013e31827777fb
McMillan SC, Small BJ, Haley WE, Zambroski C, Buck HG. The COPE Intervention for Caregivers of Patients with Heart Failure: An Adapted Intervention. J Hosp Palliat Nurs. 2013 Jun 01;15(4). doi: 10.1097/NJH.0b013e31827777fb. PMID: 24288455; PMCID: PMC3839669.
Copy Download .nbib Format: NLM
Lengthening strategies for Peyronie's disease.

Translational andrology and urology

Gaffney CD, Pagano MJ, Weinberg AC, Small AC, Kuehas FE, Egydio PH, Valenzuela RJ.
PMID: 27298782
Transl Androl Urol. 2016 Jun;5(3):351-62. doi: 10.21037/tau.2016.04.03.

Loss of penile length is a common complaint of men with Peyronie's disease (PD), both before and after corrective intervention, which has a significant negative effect on patient quality of life. We sought to identify and describe the methods...

Cite
Gaffney CD, Pagano MJ, Weinberg AC, et al. Lengthening strategies for Peyronie's disease. Transl Androl Urol. 2016;5(3):351-62doi: 10.21037/tau.2016.04.03.
Gaffney, C. D., Pagano, M. J., Weinberg, A. C., Small, A. C., Kuehas, F. E., Egydio, P. H., & Valenzuela, R. J. (2016). Lengthening strategies for Peyronie's disease. Translational andrology and urology, 5(3), 351-62. https://doi.org/10.21037/tau.2016.04.03
Gaffney, Christopher D, et al. "Lengthening strategies for Peyronie's disease." Translational andrology and urology vol. 5,3 (2016): 351-62. doi: https://doi.org/10.21037/tau.2016.04.03
Gaffney CD, Pagano MJ, Weinberg AC, Small AC, Kuehas FE, Egydio PH, Valenzuela RJ. Lengthening strategies for Peyronie's disease. Transl Androl Urol. 2016 Jun;5(3):351-62. doi: 10.21037/tau.2016.04.03. PMID: 27298782; PMCID: PMC4893519.
Copy Download .nbib Format: NLM
Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors.

Pharmacology research & perspectives

Cannady EA, Wang MD, Friedrich S, Rehmel JL, Yi P, Small DS, Zhang W, Suico JG.
PMID: 26516590
Pharmacol Res Perspect. 2015 Oct;3(5):e00179. doi: 10.1002/prp2.179. Epub 2015 Oct 12.

Evacetrapib is an investigational cholesteryl ester transfer protein inhibitor (CETPi) for reduction of risk of major adverse cardiovascular events in patients with high-risk vascular disease. Understanding evacetrapib disposition, metabolism, and the potential for drug-drug interactions (DDI) may help guide...

Cite
Cannady EA, Wang MD, Friedrich S, et al. Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors. Pharmacol Res Perspect. 2015;3(5):e00179doi: 10.1002/prp2.179.
Cannady, E. A., Wang, M. D., Friedrich, S., Rehmel, J. L., Yi, P., Small, D. S., Zhang, W., & Suico, J. G. (2015). Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors. Pharmacology research & perspectives, 3(5), e00179. https://doi.org/10.1002/prp2.179
Cannady, Ellen A, et al. "Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors." Pharmacology research & perspectives vol. 3,5 (2015): e00179. doi: https://doi.org/10.1002/prp2.179
Cannady EA, Wang MD, Friedrich S, Rehmel JL, Yi P, Small DS, Zhang W, Suico JG. Evacetrapib: in vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors. Pharmacol Res Perspect. 2015 Oct;3(5):e00179. doi: 10.1002/prp2.179. Epub 2015 Oct 12. PMID: 26516590; PMCID: PMC4618649.
Copy Download .nbib Format: NLM
EUS-guided biliary drainage or enteroscopy-assisted ERCP in patients with surgical anatomy and biliary obstruction: an international comparative study.

Endoscopy international open

Khashab MA, El Zein MH, Sharzehi K, Marson FP, Haluszka O, Small AJ, Nakai Y, Park DH, Kunda R, Teoh AY, Peñas I, Perez-Miranda M, Kumbhari V, Van der Merwe S, Artifon EL, Ross AS.
PMID: 27995197
Endosc Int Open. 2016 Dec;4(12):E1322-E1327. doi: 10.1055/s-0042-110790. Epub 2016 Aug 30.

No abstract available.

Cite
Khashab MA, El Zein MH, Sharzehi K, et al. EUS-guided biliary drainage or enteroscopy-assisted ERCP in patients with surgical anatomy and biliary obstruction: an international comparative study. Endosc Int Open. 2016;4(12):E1322-E1327doi: 10.1055/s-0042-110790.
Khashab, M. A., El Zein, M. H., Sharzehi, K., Marson, F. P., Haluszka, O., Small, A. J., Nakai, Y., Park, D. H., Kunda, R., Teoh, A. Y., Peñas, I., Perez-Miranda, M., Kumbhari, V., Van der Merwe, S., Artifon, E. L., & Ross, A. S. (2016). EUS-guided biliary drainage or enteroscopy-assisted ERCP in patients with surgical anatomy and biliary obstruction: an international comparative study. Endoscopy international open, 4(12), E1322-E1327. https://doi.org/10.1055/s-0042-110790
Khashab, Mouen A, et al. "EUS-guided biliary drainage or enteroscopy-assisted ERCP in patients with surgical anatomy and biliary obstruction: an international comparative study." Endoscopy international open vol. 4,12 (2016): E1322-E1327. doi: https://doi.org/10.1055/s-0042-110790
Khashab MA, El Zein MH, Sharzehi K, Marson FP, Haluszka O, Small AJ, Nakai Y, Park DH, Kunda R, Teoh AY, Peñas I, Perez-Miranda M, Kumbhari V, Van der Merwe S, Artifon EL, Ross AS. EUS-guided biliary drainage or enteroscopy-assisted ERCP in patients with surgical anatomy and biliary obstruction: an international comparative study. Endosc Int Open. 2016 Dec;4(12):E1322-E1327. doi: 10.1055/s-0042-110790. Epub 2016 Aug 30. PMID: 27995197; PMCID: PMC5161123.
Copy Download .nbib Format: NLM
CAUSAL INFERENCE FOR CONTINUOUS-TIME PROCESSES WHEN COVARIATES ARE OBSERVED ONLY AT DISCRETE TIMES.

Annals of statistics

Zhang M, Joffe MM, Small DS.
PMID: 24339454
Ann Stat. 2011 Feb;39(1). doi: 10.1214/10-AOS830.

Most of the work on the structural nested model and g-estimation for causal inference in longitudinal data assumes a discrete-time underlying data generating process. However, in some observational studies, it is more reasonable to assume that the data are...

Cite
Zhang M, Joffe MM, Small DS. CAUSAL INFERENCE FOR CONTINUOUS-TIME PROCESSES WHEN COVARIATES ARE OBSERVED ONLY AT DISCRETE TIMES. Ann Stat. 2011;39(1)doi: 10.1214/10-AOS830.
Zhang, M., Joffe, M. M., & Small, D. S. (2011). CAUSAL INFERENCE FOR CONTINUOUS-TIME PROCESSES WHEN COVARIATES ARE OBSERVED ONLY AT DISCRETE TIMES. Annals of statistics, 39(1), . https://doi.org/10.1214/10-AOS830
Zhang, Mingyuan, et al. "CAUSAL INFERENCE FOR CONTINUOUS-TIME PROCESSES WHEN COVARIATES ARE OBSERVED ONLY AT DISCRETE TIMES." Annals of statistics vol. 39,1 (2011). doi: https://doi.org/10.1214/10-AOS830
Zhang M, Joffe MM, Small DS. CAUSAL INFERENCE FOR CONTINUOUS-TIME PROCESSES WHEN COVARIATES ARE OBSERVED ONLY AT DISCRETE TIMES. Ann Stat. 2011 Feb;39(1). doi: 10.1214/10-AOS830. PMID: 24339454; PMCID: PMC3857358.
Copy Download .nbib Format: NLM
Progressive modification of rotors in persistent atrial fibrillation by stepwise linear ablation.

HeartRhythm case reports

Zhao J, Yao Y, Shi R, Huang W, Smaill BH, Lever NA.
PMID: 28491503
HeartRhythm Case Rep. 2015 Jan 02;1(1):22-26. doi: 10.1016/j.hrcr.2014.10.004. eCollection 2015 Jan.

No abstract available.

Cite
Zhao J, Yao Y, Shi R, et al. Progressive modification of rotors in persistent atrial fibrillation by stepwise linear ablation. HeartRhythm Case Rep. 2015;1(1):22-26doi: 10.1016/j.hrcr.2014.10.004.
Zhao, J., Yao, Y., Shi, R., Huang, W., Smaill, B. H., & Lever, N. A. (2015). Progressive modification of rotors in persistent atrial fibrillation by stepwise linear ablation. HeartRhythm case reports, 1(1), 22-26. https://doi.org/10.1016/j.hrcr.2014.10.004
Zhao, Jichao, et al. "Progressive modification of rotors in persistent atrial fibrillation by stepwise linear ablation." HeartRhythm case reports vol. 1,1 (2015): 22-26. doi: https://doi.org/10.1016/j.hrcr.2014.10.004
Zhao J, Yao Y, Shi R, Huang W, Smaill BH, Lever NA. Progressive modification of rotors in persistent atrial fibrillation by stepwise linear ablation. HeartRhythm Case Rep. 2015 Jan 02;1(1):22-26. doi: 10.1016/j.hrcr.2014.10.004. eCollection 2015 Jan. PMID: 28491503; PMCID: PMC5420065.
Copy Download .nbib Format: NLM
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance).

Cancer

Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon TD, Whitley JA, Cai L, Ahles TA, Stern RA, Jacobsen PB, Small BJ, Pitcher BN, Dura-Fernandis E, Muss HB, Hurria A, Cohen HJ, Isaacs C.
PMID: 27447359
Cancer. 2016 Nov 15;122(22):3555-3563. doi: 10.1002/cncr.30208. Epub 2016 Jul 22.

BACKGROUND: The number of survivors of breast cancer aged ≥65 years ("older") is growing, but to the authors' knowledge, little is known regarding the cognitive outcomes of these individuals.METHODS: A cohort of cognitively intact older survivors with nonmetastatic, invasive...

Cite
Mandelblatt JS, Clapp JD, Luta G, et al. Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. 2016;122(22):3555-3563doi: 10.1002/cncr.30208.
Mandelblatt, J. S., Clapp, J. D., Luta, G., Faul, L. A., Tallarico, M. D., McClendon, T. D., Whitley, J. A., Cai, L., Ahles, T. A., Stern, R. A., Jacobsen, P. B., Small, B. J., Pitcher, B. N., Dura-Fernandis, E., Muss, H. B., Hurria, A., Cohen, H. J., & Isaacs, C. (2016). Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer, 122(22), 3555-3563. https://doi.org/10.1002/cncr.30208
Mandelblatt, Jeanne S, et al. "Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)." Cancer vol. 122,22 (2016): 3555-3563. doi: https://doi.org/10.1002/cncr.30208
Mandelblatt JS, Clapp JD, Luta G, Faul LA, Tallarico MD, McClendon TD, Whitley JA, Cai L, Ahles TA, Stern RA, Jacobsen PB, Small BJ, Pitcher BN, Dura-Fernandis E, Muss HB, Hurria A, Cohen HJ, Isaacs C. Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). Cancer. 2016 Nov 15;122(22):3555-3563. doi: 10.1002/cncr.30208. Epub 2016 Jul 22. PMID: 27447359; PMCID: PMC5113662.
Copy Download .nbib Format: NLM
Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention.

Neuropsychiatry

McGuire JF, Lewin AB, Geller DA, Brown A, Ramsey K, Mutch J, Mittelman A, Micco J, Jordan C, Wilhelm S, Murphy TK, Small BJ, Storch EA.
PMID: 24174993
Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38.

Exposure-based cognitive-behavioral therapy and serotonin reuptake inhibitor medications are efficacious treatment options for the management of pediatric obsessive-compulsive disorder. Despite established efficacy, many youths receiving either therapy remain symptomatic after acute treatment. Regardless of the rationale for persistent symptoms,...

Cite
McGuire JF, Lewin AB, Geller DA, et al. Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry (London). 2012;2(4)doi: 10.2217/npy.12.38.
McGuire, J. F., Lewin, A. B., Geller, D. A., Brown, A., Ramsey, K., Mutch, J., Mittelman, A., Micco, J., Jordan, C., Wilhelm, S., Murphy, T. K., Small, B. J., & Storch, E. A. (2012). Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry, 2(4), . https://doi.org/10.2217/npy.12.38
McGuire, Joseph F, et al. "Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention." Neuropsychiatry vol. 2,4 (2012). doi: https://doi.org/10.2217/npy.12.38
McGuire JF, Lewin AB, Geller DA, Brown A, Ramsey K, Mutch J, Mittelman A, Micco J, Jordan C, Wilhelm S, Murphy TK, Small BJ, Storch EA. Advances in the treatment of pediatric obsessive-compulsive d-cycloserine with exposure and response prevention. Neuropsychiatry (London). 2012 Aug;2(4). doi: 10.2217/npy.12.38. PMID: 24174993; PMCID: PMC3808983.
Copy Download .nbib Format: NLM
How to read a blueprint.

The American journal of nursing

SMALL BJ.
PMID: 13148227
Am J Nurs. 1954 May;54(5):586-8.

No abstract available.

Cite
SMALL BJ. How to read a blueprint. Am J Nurs. 1954;54(5):586-8
SMALL, B. J. (1954). How to read a blueprint. The American journal of nursing, 54(5), 586-8.
SMALL, B J. "How to read a blueprint." The American journal of nursing vol. 54,5 (1954): 586-8.
SMALL BJ. How to read a blueprint. Am J Nurs. 1954 May;54(5):586-8. PMID: 13148227.
Copy Download .nbib Format: NLM
Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease.

Journal of Alzheimer's disease : JAD

Sáez-Valero J, Small DH.
PMID: 12214053
J Alzheimers Dis. 2001 Jun;3(3):323-328. doi: 10.3233/jad-2001-3307.

The identification of a biochemical marker in cerebrospinal fluid (CSF) that can discriminate between Alzheimer's disease (AD) and other dementia-causing diseases would be a major advance. Our previous studies have shown that the glycosylation of acetylcholinesterase (AChE) is altered...

Cite
Sáez-Valero J, Small DH. Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease. J Alzheimers Dis. 2001;3(3):323-328doi: 10.3233/jad-2001-3307.
Sáez-Valero, J., & Small, D. H. (2001). Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease. Journal of Alzheimer's disease : JAD, 3(3), 323-328. https://doi.org/10.3233/jad-2001-3307
Sáez-Valero, Javier, and Small, David H.. "Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease." Journal of Alzheimer's disease : JAD vol. 3,3 (2001): 323-328. doi: https://doi.org/10.3233/jad-2001-3307
Sáez-Valero J, Small DH. Acetylcholinesterase and butyrylcholinesterase glycoforms are biomarkers of Alzheimer's disease. J Alzheimers Dis. 2001 Jun;3(3):323-328. doi: 10.3233/jad-2001-3307. PMID: 12214053.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 297 entries